Cardiology

Acoramidis beneficial in transthyretin amyloid cardiomyopathy

Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid cardiomyopathy, according to a study published ...

Medications

The pros, cons and unknowns of popular weight-loss drugs

Nearly 42% of American adults were categorized as obese from 2017 to 2020, up from roughly 30% in 2000, according to the Centers for Disease Control and Prevention. With that rise in obesity comes an increased risk for heart ...

page 35 from 40